PEREGRINE

WIPO WIPO 2020

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die Internationale Marke PEREGRINE wurde als Wortmarke am 26.10.2020 bei der Weltorganisation für geistiges Eigentum angemeldet.

Markendetails Letztes Update: 27. Juli 2022

Markenform Wortmarke
Aktenzeichen 1572716
Länder Australien Europäische Gemeinschaft Großbritannien Japan Vereinigte Staaten von Amerika (USA)
Basismarke BX Nr. 1421682, 22. Juli 2020
Anmeldedatum 26. Oktober 2020
Ablaufdatum 26. Oktober 2030

Markeninhaber

Lichtenauerlaan 40
3062 ME Rotterdam
NL

Markenvertreter

Carnegieplein 5 2517 KJ Den Haag NL

Waren und Dienstleistungen

05 Molecular diagnostic test reagents; molecular diagnostic test reagents of body substances, such as bone marrow samples, blood samples, and on human or animal tissue; molecular diagnostic test reagents for cancer; molecular diagnostic test reagents, inter alia on the basis of microarray technology (next generation) sequencing technology; reagents for use in medical genetic testing; reagents for use in medical genetic testing for the measurement of the gene expression profile; reagents for use in medical genetic testing for the measurement of gene aberrations and mutations; clinical diagnostic test reagents for determination of genetic sub-type of a patient; prognostic test reagents; predictive test reagents, in search of the effectiveness of a medical treatment and/or to select the medical treatment; diagnostic test reagents and preparations for medical or veterinary purposes; chemical preparations, for medical purposes, for the testing of blood and human or animal tissue, including cancer cells; medical diagnostic test strips; diagnostic testing materials for medical use; preparations for detecting mutation in genes for medical purposes
42 Research and development of new products for others; biochemical research and development; pharmaceutical research and development; research and development in the field of diagnostic preparations; biological research, clinical research and medical research; scientific research for the benefit of the development of molecular diagnostic tests; analysis and evaluation of results from quality control tests; molecular diagnostic analysis; investigation and analysis of body substances and molecular diagnostic test scores for the purpose of the development of new biomarkers; development and diagnostic testing of treatment methods; development and testing services for the certification of quality or standards of (molecular) diagnostic tests; computer aided diagnostic testing services; scientific research for medical purposes in the area of cancerous diseases; genetic testing for scientific research purposes; research in the field of gene therapy; research and diagnostic testing services in the field of skin cancer
44 Medical analysis services; medical analysis services using test scores and data for medical or veterinary purposes for others; medical and veterinary information services provided via the internet; medical testing for diagnostic or treatment purposes; medical diagnostic services; medical analysis services for cancer diagnosis and prognosis; medical services for the treatment of skin cancer; medical analysis services for the diagnosis of cancer
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

Markenhistorie

Datum Belegnummer Bereich Eintrag
22. Juli 2022 2022/30 Gaz US RAW: Rule 18ter(2)(ii) GP following a provisional refusal
12. April 2022 2022/21 Gaz AU RAW: Rule 18ter(2)(ii) GP following a provisional refusal
02. Dezember 2021 2021/48 Gaz JP Ablehnung
18. August 2021 2021/33 Gaz GB Ablehnung
16. Juni 2021 2021/24 Gaz EM Ablehnung
08. April 2021 2021/14 Gaz US Ablehnung
19. Februar 2021 2021/8 Gaz AU Ablehnung
26. Oktober 2020 2021/2 Gaz BX Eintragung

ID: 141572716